337 related articles for article (PubMed ID: 31320495)
1. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.
Miner NB; Phillips TJ; Janowsky A
J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495
[TBL] [Abstract][Full Text] [Related]
2. Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.
Miner NB; Elmore JS; Baumann MH; Phillips TJ; Janowsky A
Neurotoxicology; 2017 Dec; 63():57-69. PubMed ID: 28919515
[TBL] [Abstract][Full Text] [Related]
3. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
4. A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2009 Jul; 330(1):316-25. PubMed ID: 19364908
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.
Lu T; Kim PP; Greig NH; Luo Y
Neurotox Res; 2017 Aug; 32(2):218-230. PubMed ID: 28342134
[TBL] [Abstract][Full Text] [Related]
6. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
[TBL] [Abstract][Full Text] [Related]
7. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
8. Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.
Shi X; Swanson TL; Miner NB; Eshleman AJ; Janowsky A
Mol Pharmacol; 2019 Oct; 96(4):493-504. PubMed ID: 31409621
[TBL] [Abstract][Full Text] [Related]
9. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
11. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in dopamine- and vesicular monoamine-transporter functions.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
[TBL] [Abstract][Full Text] [Related]
14. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.
Bourque M; Liu B; Dluzen DE; Di Paolo T
Psychoneuroendocrinology; 2011 Aug; 36(7):955-69. PubMed ID: 21236583
[TBL] [Abstract][Full Text] [Related]
16. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.
Lohr KM; Stout KA; Dunn AR; Wang M; Salahpour A; Guillot TS; Miller GW
ACS Chem Neurosci; 2015 May; 6(5):790-9. PubMed ID: 25746685
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.
Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
Synapse; 2009 Feb; 63(2):147-51. PubMed ID: 19021208
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice.
Fukushima S; Shen H; Hata H; Ohara A; Ohmi K; Ikeda K; Numachi Y; Kobayashi H; Hall FS; Uhl GR; Sora I
Psychopharmacology (Berl); 2007 Jul; 193(1):55-62. PubMed ID: 17377774
[TBL] [Abstract][Full Text] [Related]
19. Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.
D'Astous M; Mickley KR; Dluzen DE; Di Paolo T
Neuroendocrinology; 2005; 82(2):111-20. PubMed ID: 16446547
[TBL] [Abstract][Full Text] [Related]
20. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
Guillot TS; Shepherd KR; Richardson JR; Wang MZ; Li Y; Emson PC; Miller GW
J Neurochem; 2008 Sep; 106(5):2205-17. PubMed ID: 18643795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
